The single-rod, etonogestrel-releasing, subdermal implant (ENG implant) is the most effective, long-acting reversible method of contraception available. The failure rate of the ENG implant is 0.05 ...

Matthew Whelan, also known as King of Ink Land King Body Art the Extreme Ink-Ite, has found himself in a pre-Christmas pickle ...

The company plans to leverage research and development incentives from the Australian Government to offset the trial costs.

The trial investigates the safety, tolerability, and full pharmacokinetic profile of an exenatide implant. Vivani’s lead ...

The 3 methods of long-term contraception (LTC) approved for use in the US are intrauterine devices (IUDs), levonorgestrel subdermal implants, and sustained-release medroxyprogesterone acetate ...

The trial investigates the safety, tolerability, and full pharmacokinetic profile of an exenatide implant. Vivani’s lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1 ...

subdermal implants based on its proprietary NanoPortal technology platform to enable long-term, near constant-rate delivery of a broad range of medicines to eliminate medication non-adherence ...

Vivani Medical, Inc. (NASDAQ: VANI) (the "Company" or "Vivani"), an innovative biopharmaceutical company developing ...

Presentation: Advancing Chronic Disease Management with Ultra Long-Acting Miniature Subdermal Implants of GLP-1 Presentation Date: Wednesday, December 11, 2024 Presentation Time: 4:20pm, Pacific Time ...

Presentation: Advancing Chronic Disease Management with Ultra Long-Acting Miniature Subdermal Implants of GLP-1 Presentation Date: Wednesday, December 11, 2024 Presentation Time: 4:20pm ...